Table 1

Baseline patient characteristics between respiratory muscle weakness with and without frailty

OverallNon-frailFrail
(n = 1217)(n = 922)(n = 295)
RMW (−)RMW (+)P-valueRMW (−)RMW (+)P-value
(n = 615)(n = 307)(n = 146)(n = 149)
Age69 ± 1467 ± 1371 ± 14<0.00173 ± 1373 ± 140.758
Sex, n (%)
 Female380 (31.2)193 (31.4)95 (30.9)0.94042 (28.8)50 (33.6)0.382
 Male837 (68.8)422 (68.6)212 (69.1)104 (71.2)99 (66.4)
Heart rate, beat/min77 ± 2077 ± 2276 ± 170.45779 ± 2079 ± 190.861
sBP, mmHg115 ± 19115 ± 19116 ± 190.305113 ± 20114 ± 200.627
dBP, mmHg67 ± 1368 ± 1367 ± 140.23867 ± 1266 ± 130.673
BMI, kg/m222.6 ± 3.923.2 ± 3.622.8 ± 4.20.18621.2 ± 3.821.1 ± 3.90.791
Cause of admission, n (%)
 ACS300 (24.7)190 (30.9)68 (22.1)0.00516 (11.0)26 (17.4)0.134
 Heart failure685 (56.3)296 (48.1)186 (60.6)<0.00198 (67.1)105 (70.5)0.615
 Current smoker, n (%)267 (22.2)151 (24.9)50 (16.5)0.00435 (24.1)31 (21.1)0.577
Comorbidities, n (%)
 Hypertension751 (61.7)383 (62.3)191 (62.2)1.00082 (56.2)95 (63.8)0.193
 Dyslipidaemia488 (40.1)276 (44.9)110 (35.8)0.00944 (30.1)58 (38.9)0.142
 Diabetes mellitus399 (32.8)198 (32.2)87 (28.3)0.25751 (34.9)63 (42.3)0.232
 Ischaemic heart disease227 (18.7)107 (17.4)63 (20.5)0.28028 (19.2)29 (19.5)1.000
 Atrial fibrillation313 (25.7)134 (21.8)88 (28.7)0.02251 (34.9)40 (26.8)0.086
 Chronic kidney disease821 (67.5)380 (61.8)229 (74.6)<0.001108 (74.0)104 (69.8)0.440
Medications, n (%)
 ACE-I or ARB932 (76.6)469 (76.3)239 (77.9)0.620109 (74.7)115 (77.2)0.683
 Beta-blockers878 (72.1)446 (72.5)220 (71.7)0.815102 (69.9)110 (73.8)0.518
 Diuretics859 (70.6)405 (65.9)220 (71.7)0.085115 (78.8)119 (79.9)0.886
 Loop diuretics395 (32.5)170 (27.6)114 (37.1)0.00452 (35.6)59 (39.6)0.548
 MRA381 (31.3)177 (28.8)97 (31.6)0.40152 (35.6)55 (36.9)0.904
 Statin667 (54.8)354 (57.6)166 (54.1)0.32471 (48.6)76 (51.0)0.727
LVEF, %50.9 ± 16.951.4 ± 16.051.2 ± 16.70.83249.9 ± 19.049.3 ± 19.10.788
Haemoglobin, g/dL12.4 ± 2.212.8 ± 2.112.1 ± 2.2<0.00112.0 ± 2.211.7 ± 2.20.290
Albumin, g/dL3.6 ± 0.63.8 ± 0.63.7 ± 0.50.0193.5 ± 0.63.3 ± 0.60.063
BUN, mg/dL19.0 (14.3–26.2)17.8 (13.9–23.6)18.3 (14.1–25.9)0.12121.8 (16.1–30.2)23.3 (17.1–31.6)0.277
Creatinine, mg/dL1.03 (0.83–1.36)1.01 (0.82–1.29)1.06 (0.86–1.39)0.0111.09 (0.87–1.50)1.16 (0.84–1.68)0.422
eGFR, mL/min/1.73 m250.0 (35.5–65.0)55.0 (40.5–66.0)47.0 (34.0–63.0)<0.00149.0 (29.0–64.0)45.0 (28.0–64.0)0.692
CRP, mg/dL0.42 (0.13–1.36)0.40 (0.12–1.25)0.36 (0.13–1.49)0.6070.57 (0.13–1.68)0.54 (0.26–1.44)0.616
BNP, pg/mL317.0 (91.6–794.0)231.4 (51.8–632.2)393.1 (113.0–937.8)<0.001413.1 (184.5–894.9)475.0 (164.5–1051.6)0.515
OverallNon-frailFrail
(n = 1217)(n = 922)(n = 295)
RMW (−)RMW (+)P-valueRMW (−)RMW (+)P-value
(n = 615)(n = 307)(n = 146)(n = 149)
Age69 ± 1467 ± 1371 ± 14<0.00173 ± 1373 ± 140.758
Sex, n (%)
 Female380 (31.2)193 (31.4)95 (30.9)0.94042 (28.8)50 (33.6)0.382
 Male837 (68.8)422 (68.6)212 (69.1)104 (71.2)99 (66.4)
Heart rate, beat/min77 ± 2077 ± 2276 ± 170.45779 ± 2079 ± 190.861
sBP, mmHg115 ± 19115 ± 19116 ± 190.305113 ± 20114 ± 200.627
dBP, mmHg67 ± 1368 ± 1367 ± 140.23867 ± 1266 ± 130.673
BMI, kg/m222.6 ± 3.923.2 ± 3.622.8 ± 4.20.18621.2 ± 3.821.1 ± 3.90.791
Cause of admission, n (%)
 ACS300 (24.7)190 (30.9)68 (22.1)0.00516 (11.0)26 (17.4)0.134
 Heart failure685 (56.3)296 (48.1)186 (60.6)<0.00198 (67.1)105 (70.5)0.615
 Current smoker, n (%)267 (22.2)151 (24.9)50 (16.5)0.00435 (24.1)31 (21.1)0.577
Comorbidities, n (%)
 Hypertension751 (61.7)383 (62.3)191 (62.2)1.00082 (56.2)95 (63.8)0.193
 Dyslipidaemia488 (40.1)276 (44.9)110 (35.8)0.00944 (30.1)58 (38.9)0.142
 Diabetes mellitus399 (32.8)198 (32.2)87 (28.3)0.25751 (34.9)63 (42.3)0.232
 Ischaemic heart disease227 (18.7)107 (17.4)63 (20.5)0.28028 (19.2)29 (19.5)1.000
 Atrial fibrillation313 (25.7)134 (21.8)88 (28.7)0.02251 (34.9)40 (26.8)0.086
 Chronic kidney disease821 (67.5)380 (61.8)229 (74.6)<0.001108 (74.0)104 (69.8)0.440
Medications, n (%)
 ACE-I or ARB932 (76.6)469 (76.3)239 (77.9)0.620109 (74.7)115 (77.2)0.683
 Beta-blockers878 (72.1)446 (72.5)220 (71.7)0.815102 (69.9)110 (73.8)0.518
 Diuretics859 (70.6)405 (65.9)220 (71.7)0.085115 (78.8)119 (79.9)0.886
 Loop diuretics395 (32.5)170 (27.6)114 (37.1)0.00452 (35.6)59 (39.6)0.548
 MRA381 (31.3)177 (28.8)97 (31.6)0.40152 (35.6)55 (36.9)0.904
 Statin667 (54.8)354 (57.6)166 (54.1)0.32471 (48.6)76 (51.0)0.727
LVEF, %50.9 ± 16.951.4 ± 16.051.2 ± 16.70.83249.9 ± 19.049.3 ± 19.10.788
Haemoglobin, g/dL12.4 ± 2.212.8 ± 2.112.1 ± 2.2<0.00112.0 ± 2.211.7 ± 2.20.290
Albumin, g/dL3.6 ± 0.63.8 ± 0.63.7 ± 0.50.0193.5 ± 0.63.3 ± 0.60.063
BUN, mg/dL19.0 (14.3–26.2)17.8 (13.9–23.6)18.3 (14.1–25.9)0.12121.8 (16.1–30.2)23.3 (17.1–31.6)0.277
Creatinine, mg/dL1.03 (0.83–1.36)1.01 (0.82–1.29)1.06 (0.86–1.39)0.0111.09 (0.87–1.50)1.16 (0.84–1.68)0.422
eGFR, mL/min/1.73 m250.0 (35.5–65.0)55.0 (40.5–66.0)47.0 (34.0–63.0)<0.00149.0 (29.0–64.0)45.0 (28.0–64.0)0.692
CRP, mg/dL0.42 (0.13–1.36)0.40 (0.12–1.25)0.36 (0.13–1.49)0.6070.57 (0.13–1.68)0.54 (0.26–1.44)0.616
BNP, pg/mL317.0 (91.6–794.0)231.4 (51.8–632.2)393.1 (113.0–937.8)<0.001413.1 (184.5–894.9)475.0 (164.5–1051.6)0.515

Values are mean ± SD, or median (interquartile range).

ACE-I, angiotensin-convertor enzyme inhibitor; ACS, acute coronary syndrome; ARB, angiotensin II receptor blocker; BMI, body mass index; BNP, brain natriuretic peptide; BUN, blood urea nitrogen; CRP, C-reactive protein; dBP, diastolic blood pressure; eGFR, estimated glomerular filtration rate; LVEF, left ventricular ejection fraction; MRA, mineralocorticoid receptor antagonist; RMW, respiratory muscle weakness; sBP, systolic blood pressure.

Table 1

Baseline patient characteristics between respiratory muscle weakness with and without frailty

OverallNon-frailFrail
(n = 1217)(n = 922)(n = 295)
RMW (−)RMW (+)P-valueRMW (−)RMW (+)P-value
(n = 615)(n = 307)(n = 146)(n = 149)
Age69 ± 1467 ± 1371 ± 14<0.00173 ± 1373 ± 140.758
Sex, n (%)
 Female380 (31.2)193 (31.4)95 (30.9)0.94042 (28.8)50 (33.6)0.382
 Male837 (68.8)422 (68.6)212 (69.1)104 (71.2)99 (66.4)
Heart rate, beat/min77 ± 2077 ± 2276 ± 170.45779 ± 2079 ± 190.861
sBP, mmHg115 ± 19115 ± 19116 ± 190.305113 ± 20114 ± 200.627
dBP, mmHg67 ± 1368 ± 1367 ± 140.23867 ± 1266 ± 130.673
BMI, kg/m222.6 ± 3.923.2 ± 3.622.8 ± 4.20.18621.2 ± 3.821.1 ± 3.90.791
Cause of admission, n (%)
 ACS300 (24.7)190 (30.9)68 (22.1)0.00516 (11.0)26 (17.4)0.134
 Heart failure685 (56.3)296 (48.1)186 (60.6)<0.00198 (67.1)105 (70.5)0.615
 Current smoker, n (%)267 (22.2)151 (24.9)50 (16.5)0.00435 (24.1)31 (21.1)0.577
Comorbidities, n (%)
 Hypertension751 (61.7)383 (62.3)191 (62.2)1.00082 (56.2)95 (63.8)0.193
 Dyslipidaemia488 (40.1)276 (44.9)110 (35.8)0.00944 (30.1)58 (38.9)0.142
 Diabetes mellitus399 (32.8)198 (32.2)87 (28.3)0.25751 (34.9)63 (42.3)0.232
 Ischaemic heart disease227 (18.7)107 (17.4)63 (20.5)0.28028 (19.2)29 (19.5)1.000
 Atrial fibrillation313 (25.7)134 (21.8)88 (28.7)0.02251 (34.9)40 (26.8)0.086
 Chronic kidney disease821 (67.5)380 (61.8)229 (74.6)<0.001108 (74.0)104 (69.8)0.440
Medications, n (%)
 ACE-I or ARB932 (76.6)469 (76.3)239 (77.9)0.620109 (74.7)115 (77.2)0.683
 Beta-blockers878 (72.1)446 (72.5)220 (71.7)0.815102 (69.9)110 (73.8)0.518
 Diuretics859 (70.6)405 (65.9)220 (71.7)0.085115 (78.8)119 (79.9)0.886
 Loop diuretics395 (32.5)170 (27.6)114 (37.1)0.00452 (35.6)59 (39.6)0.548
 MRA381 (31.3)177 (28.8)97 (31.6)0.40152 (35.6)55 (36.9)0.904
 Statin667 (54.8)354 (57.6)166 (54.1)0.32471 (48.6)76 (51.0)0.727
LVEF, %50.9 ± 16.951.4 ± 16.051.2 ± 16.70.83249.9 ± 19.049.3 ± 19.10.788
Haemoglobin, g/dL12.4 ± 2.212.8 ± 2.112.1 ± 2.2<0.00112.0 ± 2.211.7 ± 2.20.290
Albumin, g/dL3.6 ± 0.63.8 ± 0.63.7 ± 0.50.0193.5 ± 0.63.3 ± 0.60.063
BUN, mg/dL19.0 (14.3–26.2)17.8 (13.9–23.6)18.3 (14.1–25.9)0.12121.8 (16.1–30.2)23.3 (17.1–31.6)0.277
Creatinine, mg/dL1.03 (0.83–1.36)1.01 (0.82–1.29)1.06 (0.86–1.39)0.0111.09 (0.87–1.50)1.16 (0.84–1.68)0.422
eGFR, mL/min/1.73 m250.0 (35.5–65.0)55.0 (40.5–66.0)47.0 (34.0–63.0)<0.00149.0 (29.0–64.0)45.0 (28.0–64.0)0.692
CRP, mg/dL0.42 (0.13–1.36)0.40 (0.12–1.25)0.36 (0.13–1.49)0.6070.57 (0.13–1.68)0.54 (0.26–1.44)0.616
BNP, pg/mL317.0 (91.6–794.0)231.4 (51.8–632.2)393.1 (113.0–937.8)<0.001413.1 (184.5–894.9)475.0 (164.5–1051.6)0.515
OverallNon-frailFrail
(n = 1217)(n = 922)(n = 295)
RMW (−)RMW (+)P-valueRMW (−)RMW (+)P-value
(n = 615)(n = 307)(n = 146)(n = 149)
Age69 ± 1467 ± 1371 ± 14<0.00173 ± 1373 ± 140.758
Sex, n (%)
 Female380 (31.2)193 (31.4)95 (30.9)0.94042 (28.8)50 (33.6)0.382
 Male837 (68.8)422 (68.6)212 (69.1)104 (71.2)99 (66.4)
Heart rate, beat/min77 ± 2077 ± 2276 ± 170.45779 ± 2079 ± 190.861
sBP, mmHg115 ± 19115 ± 19116 ± 190.305113 ± 20114 ± 200.627
dBP, mmHg67 ± 1368 ± 1367 ± 140.23867 ± 1266 ± 130.673
BMI, kg/m222.6 ± 3.923.2 ± 3.622.8 ± 4.20.18621.2 ± 3.821.1 ± 3.90.791
Cause of admission, n (%)
 ACS300 (24.7)190 (30.9)68 (22.1)0.00516 (11.0)26 (17.4)0.134
 Heart failure685 (56.3)296 (48.1)186 (60.6)<0.00198 (67.1)105 (70.5)0.615
 Current smoker, n (%)267 (22.2)151 (24.9)50 (16.5)0.00435 (24.1)31 (21.1)0.577
Comorbidities, n (%)
 Hypertension751 (61.7)383 (62.3)191 (62.2)1.00082 (56.2)95 (63.8)0.193
 Dyslipidaemia488 (40.1)276 (44.9)110 (35.8)0.00944 (30.1)58 (38.9)0.142
 Diabetes mellitus399 (32.8)198 (32.2)87 (28.3)0.25751 (34.9)63 (42.3)0.232
 Ischaemic heart disease227 (18.7)107 (17.4)63 (20.5)0.28028 (19.2)29 (19.5)1.000
 Atrial fibrillation313 (25.7)134 (21.8)88 (28.7)0.02251 (34.9)40 (26.8)0.086
 Chronic kidney disease821 (67.5)380 (61.8)229 (74.6)<0.001108 (74.0)104 (69.8)0.440
Medications, n (%)
 ACE-I or ARB932 (76.6)469 (76.3)239 (77.9)0.620109 (74.7)115 (77.2)0.683
 Beta-blockers878 (72.1)446 (72.5)220 (71.7)0.815102 (69.9)110 (73.8)0.518
 Diuretics859 (70.6)405 (65.9)220 (71.7)0.085115 (78.8)119 (79.9)0.886
 Loop diuretics395 (32.5)170 (27.6)114 (37.1)0.00452 (35.6)59 (39.6)0.548
 MRA381 (31.3)177 (28.8)97 (31.6)0.40152 (35.6)55 (36.9)0.904
 Statin667 (54.8)354 (57.6)166 (54.1)0.32471 (48.6)76 (51.0)0.727
LVEF, %50.9 ± 16.951.4 ± 16.051.2 ± 16.70.83249.9 ± 19.049.3 ± 19.10.788
Haemoglobin, g/dL12.4 ± 2.212.8 ± 2.112.1 ± 2.2<0.00112.0 ± 2.211.7 ± 2.20.290
Albumin, g/dL3.6 ± 0.63.8 ± 0.63.7 ± 0.50.0193.5 ± 0.63.3 ± 0.60.063
BUN, mg/dL19.0 (14.3–26.2)17.8 (13.9–23.6)18.3 (14.1–25.9)0.12121.8 (16.1–30.2)23.3 (17.1–31.6)0.277
Creatinine, mg/dL1.03 (0.83–1.36)1.01 (0.82–1.29)1.06 (0.86–1.39)0.0111.09 (0.87–1.50)1.16 (0.84–1.68)0.422
eGFR, mL/min/1.73 m250.0 (35.5–65.0)55.0 (40.5–66.0)47.0 (34.0–63.0)<0.00149.0 (29.0–64.0)45.0 (28.0–64.0)0.692
CRP, mg/dL0.42 (0.13–1.36)0.40 (0.12–1.25)0.36 (0.13–1.49)0.6070.57 (0.13–1.68)0.54 (0.26–1.44)0.616
BNP, pg/mL317.0 (91.6–794.0)231.4 (51.8–632.2)393.1 (113.0–937.8)<0.001413.1 (184.5–894.9)475.0 (164.5–1051.6)0.515

Values are mean ± SD, or median (interquartile range).

ACE-I, angiotensin-convertor enzyme inhibitor; ACS, acute coronary syndrome; ARB, angiotensin II receptor blocker; BMI, body mass index; BNP, brain natriuretic peptide; BUN, blood urea nitrogen; CRP, C-reactive protein; dBP, diastolic blood pressure; eGFR, estimated glomerular filtration rate; LVEF, left ventricular ejection fraction; MRA, mineralocorticoid receptor antagonist; RMW, respiratory muscle weakness; sBP, systolic blood pressure.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close